CD4 and myeloid sarcoma: An accumulation of cytotoxic CD4+ T cells was observed in patients with multiple sclerosis (MS) [65,66], inflammatory bowel disease (IBD) [67], rheumatoid arthritis (RA) [68], and ankylosing spondylitis [69].